具特色的競爭優勢

在競爭激烈的藥品市場中，企業唯有持續強化競爭優勢才能賴以生存；故晟德大藥廠始終專注於創新──從產品研發、組織管理、廠房設備、製造環境、生產品質控制，到服務技術與銷售人員進行多面向的整合經營模式，此核心競爭力的價值體系包括：
‧致力研發以創造高度市場差異
以創新精神開發各種口味佳、高品質、高價值的差異化產品。
‧標準製程輔以高效率後勤系統
以標準規格化及自動化的生產流程，提高產能並降低成本；再輔以快速的物流倉儲、配送及ERP後勤系統。
‧打造客戶導向的專業服務團隊
以專業及經驗豐富的銷售團隊，秉持以客戶為導向的行銷支援精神，進行整合價值體系的服務。

創造績效 啟動成長契機

晟德大藥廠一向致力於生產高品質的內服液劑藥品，更在充分授權的團隊機制下，不但提升了製造效率，並導入嚴格的品管流程──堅持以人為本的理念，確保藥品在PIC/S之安全認可下，建立對所有消費者健康的標準。
此外，晟德以價值導向取代價格競爭，為顧客提供快速、貼心的服務，因而能與客戶建立穩定長期的合作夥伴關係。近年來，在專業團隊的經營模式下，啟動了快速成長的契機與卓越經營績效包括：
‧ 2003年10月正式上櫃。
‧ 2004年通過cGMP三階段審查。
‧ 2010年通過PIC/S歐盟規格標準。
‧每年營業收入成長率超過15%，營業利益成長率達20~30%，新增有效客戶300~400個。
‧每年以營業收入的5~10%作為研發經費，並設定開發3~5個產品為目標。
‧ 存貨週轉率達10，資本運用效率為同業中最高。

Features competitive advantage

Only those companies that continue to strengthen their competitive advantages can survive in today's intensely competitive drug market. At Center Laboratories we can rely on an unwavering commitment to innovation. Our multi-faceted, integrated business model spans product R&D, organizational management, plant equipment, the production environment, production quality control, and even service technology and sales personnel. Our core value system includes:

‧R&D to create clear-cut market differentiation:

Our innovative spirit emerges in many kinds of good-tasting, high-quality, high-value differentiated products.

‧Standard processes plus a highly efficient logistics system:

The use of standard specifications and automated production processes has boosted our production capacity and cut costs; our fast storage, distribution, and ERP logistics system gives us an added edge.

‧A customer-oriented professional service team:

Our professional and highly experienced sales team provides customer-oriented marketing support while supporting our integrated value system.

 Delivering High Performance andCapitalizing on Opportunities for Growth

We are dedicated to producing the highest quality oral liquid drugs. In keeping with our people-centered philosophy, we rely on our fully authorized employee teams to achieve maximum production efficiency and implement our strict QC procedures. cGMP processes ensure safe drugs and protect consumers' health.

Center Laboratories wants to replace price competition with a value-oriented outlook. We believe that our quick, considerate service has allowed us to establish stable long-term partnerships with our customers. Our professional team business model has recently opened up some opportunities for rapid growth, and our performance milestones include the following:

‧2003, October – Start of formal OTC trading. 

‧2004 – Passed cGMP stage 3 review.

‧Annual operating income growth rate exceeding 15%, annual operating profit growth rate of 30~40%, 300 - 400 new customers each year.

‧We re-invest 5~10% of our annual income in R&D, and we have set a target of developing 3~5 new products every year.

‧      Inventory turnover above 10, capital utilization efficiency the highest in the industry.